Cargando…
Bisphosphonate use after clinical fracture and risk of new fracture
SUMMARY: Among older adults with a previous fracture, treatment for osteoporosis was initially associated with a higher risk of new fracture. However, the relative risk of new fracture decreased over time, a trend that is consistent with a beneficial effect, as treatment for osteoporosis is prescrib...
Autores principales: | Bergman, J., Nordström, A., Nordström, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854733/ https://www.ncbi.nlm.nih.gov/pubmed/29397408 http://dx.doi.org/10.1007/s00198-017-4367-7 |
Ejemplares similares
-
Bisphosphonates and mortality: confounding in observational studies?
por: Bergman, J., et al.
Publicado: (2019) -
Correction to: Bisphosphonates and mortality: confounding in observational studies
por: Bergman, J., et al.
Publicado: (2021) -
Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort
por: Nordström, P., et al.
Publicado: (2019) -
Trends in Hip Fracture Incidence, Length of Hospital Stay, and 30-Day Mortality in Sweden from 1998–2017: A Nationwide Cohort Study
por: Nordström, Peter, et al.
Publicado: (2022) -
Longitudinal change in clinical fracture incidence after initiation of bisphosphonates
por: Abelson, A., et al.
Publicado: (2009)